Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Hepatitis C virus (HCV) and triglyceride-rich very low-density lipoproteins (VLDLs) both are secreted uniquely by hepatocytes and circulate in blood in a complex. Here, we isolated from human hepatoma cells the membrane vesicles in which HCV replicates. These vesicles, which contain the HCV replication complex, are highly enriched in proteins required for VLDL assembly, including apolipoprotein B (apoB), apoE, and microsomal triglyceride transfer protein. In hepatoma cells that constitutively produce infectious HCV, HCV production is reduced by two agents that block VLDL assembly: an inhibitor of microsomal triglyceride transfer protein and siRNA directed against apoB. These results provide a possible explanation for the restriction of HCV production to the liver and suggest new cellular targets for treatment of HCV infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ASSEMBLY OF ASPARAGINE-LINKED OLIGOSACCHARIDES
Kornfeld, R., & Kornfeld, S. (1985) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.54.070185.003215 · Cited by 4,906
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line
Lohmann, V., Körner, F., Koch, J.-O., Herian, U., Theilmann, L., & Bartenschlager, R. (1999) · Science · doi:10.1126/science.285.5424.110 · Cited by 2,814
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
Soutschek, J., Akinc, A., Bramlage, B., Charisse, K., Constien, R., Donoghue, M., Elbashir, S., Geick, A., Hadwiger, P., Harborth, J., et al. (2004) · Nature · doi:10.1038/nature03121 · Cited by 2,183
RNAi-mediated gene silencing in non-human primates
Zimmermann, T. S., Lee, A. C. H., Akinc, A., Bramlage, B., Bumcrot, D., Fedoruk, M. N., Harborth, J., Heyes, J. A., Jeffs, L. B., John, M., et al. (2006) · Nature · doi:10.1038/nature04688 · Cited by 1,357
Highly Permissive Cell Lines for Subgenomic and Genomic Hepatitis C Virus RNA Replication
Blight, K. J., McKeating, J. A., & Rice, C. M. (2002) · Journal of Virology · doi:10.1128/jvi.76.24.13001-13014.2002 · Cited by 1,193
The mechanism of Z α1-antitrypsin accumulation in the liver
Lomas, D. A., LI-Evans, D., Finch, J. T., & Carrell, R. W. (1992) · Nature · doi:10.1038/357605a0 · Cited by 1,053
Egger, D., Wölk, B., Gosert, R., Bianchi, L., Blum, H. E., Moradpour, D., & Bienz, K. (2002) · Journal of Virology · doi:10.1128/jvi.76.12.5974-5984.2002 · Cited by 867
Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles
André, P., Komurian-Pradel, F., Deforges, S., Perret, M., Berland, J. L., Sodoyer, M., Pol, S., Bréchot, C., Paranhos-Baccalà, G., & Lotteau, V. (2002) · Journal of Virology · doi:10.1128/jvi.76.14.6919-6928.2002 · Cited by 690
Gosert, R., Egger, D., Lohmann, V., Bartenschlager, R., Blum, H. E., Bienz, K., & Moradpour, D. (2003) · Journal of Virology · doi:10.1128/jvi.77.9.5487-5492.2003 · Cited by 635
Cited by
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Replication of hepatitis C virus
Moradpour, D., Penin, F., & Rice, C. M. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1645 · Cited by 1,336
Dengue Virus-Induced Autophagy Regulates Lipid Metabolism
Heaton, N. S., & Randall, G. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.10.006 · Cited by 705
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
Scheel, T. K. H., & Rice, C. M. (2013) · Nature Medicine · doi:10.1038/nm.3248 · Cited by 554
Phospholipid Remodeling in Physiology and Disease
Wang, B., & Tontonoz, P. (2019) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020518-114444 · Cited by 527
A TALEN Genome-Editing System for Generating Human Stem Cell-Based Disease Models
Ding, Q., Lee, Y.-K., Schaefer, E. A. K., Peters, D. T., Veres, A., Kim, K., Kuperwasser, N., Motola, D. L., Meissner, T. B., Hendriks, W. T., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2012.11.011 · Cited by 501
Appel, N., Zayas, M., Miller, S., Krijnse-Locker, J., Schaller, T., Friebe, P., Kallis, S., Engel, U., & Bartenschlager, R. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000035 · Cited by 466
Cellular Determinants of Hepatitis C Virus Assembly, Maturation, Degradation, and Secretion
Gastaminza, P., Cheng, G., Wieland, S., Zhong, J., Liao, W., & Chisari, F. V. (2008) · Journal of Virology · doi:10.1128/jvi.02053-07 · Cited by 463
Assembly of infectious hepatitis C virus particles
Bartenschlager, R., Penin, F., Lohmann, V., & André, P. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2010.11.005 · Cited by 453
Sainz, B., Barretto, N., Martin, D. N., Hiraga, N., Imamura, M., Hussain, S., Marsh, K. A., Yu, X., Chayama, K., Alrefai, W. A., et al. (2012) · Nature Medicine · doi:10.1038/nm.2581 · Cited by 452
Chang, K.-S., Jiang, J., Cai, Z., & Luo, G. (2007) · Journal of Virology · doi:10.1128/jvi.01091-07 · Cited by 424
Diamond, D. L., Syder, A. J., Jacobs, J. M., Sorensen, C. M., Walters, K.-A., Proll, S. C., McDermott, J. E., Gritsenko, M. A., Zhang, Q., Zhao, R., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000719 · Cited by 412
The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection
Bartenschlager, R., Lohmann, V., & Penin, F. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3046 · Cited by 402
The ins and outs of hepatitis C virus entry and assembly
Lindenbach, B. D., & Rice, C. M. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3098 · Cited by 387
Hepatitis C virus hijacks host lipid metabolism
Syed, G. H., Amako, Y., & Siddiqui, A. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.07.005 · Cited by 363
Merz, A., Long, G., Hiet, M.-S., Brügger, B., Chlanda, P., Andre, P., Wieland, F., Krijnse-Locker, J., & Bartenschlager, R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.175018 · Cited by 356
Efficient hepatitis C virus particle formation requires diacylglycerol acyltransferase-1
Herker, E., Harris, C., Hernandez, C., Carpentier, A., Kaehlcke, K., Rosenberg, A. R., Farese, R. V., & Ott, M. (2010) · Nature Medicine · doi:10.1038/nm.2238 · Cited by 350
Carboxylesterases in lipid metabolism: from mouse to human
Lian, J., Nelson, R., & Lehner, R. (2018) · Protein & Cell · doi:10.1007/s13238-017-0437-z · Cited by 300
Weidner, J. M., Jiang, D., Pan, X.-B., Chang, J., Block, T. M., & Guo, J.-T. (2010) · Journal of Virology · doi:10.1128/jvi.01328-10 · Cited by 285
Nahmias, Y., Goldwasser, J., Casali, M., van Poll, D., Wakita, T., Chung, R. T., & Yarmush, M. L. (2008) · Hepatology · doi:10.1002/hep.22197 · Cited by 279
Role of Lipids in Virus Replication
Lorizate, M., & Krausslich, H.-G. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004820 · Cited by 278
Shavinskaya, A., Boulant, S., Penin, F., McLauchlan, J., & Bartenschlager, R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707329200 · Cited by 275
Multiple functions of microsomal triglyceride transfer protein
Hussain, M. M., Rava, P., Walsh, M., Rana, M., & Iqbal, J. (2012) · Nutrition & Metabolism · doi:10.1186/1743-7075-9-14 · Cited by 261
Apolipoprotein E but Not B Is Required for the Formation of Infectious Hepatitis C Virus Particles
Jiang, J., & Luo, G. (2009) · Journal of Virology · doi:10.1128/jvi.01476-09 · Cited by 255
Tutunchi, H., Naeini, F., Ostadrahimi, A., & Hosseinzadeh‐Attar, M. J. (2020) · Phytotherapy Research · doi:10.1002/ptr.6781 · Cited by 255
Abnormalities of lipid metabolism in hepatitis C virus infection
Negro, F. (2010) · Gut · doi:10.1136/gut.2009.192732 · Cited by 162
Autophagy Protects Cells From HCV-Induced Defects in Lipid Metabolism
Vescovo, T., Romagnoli, A., Perdomo, A. B., Corazzari, M., Ciccosanti, F., Alonzi, T., Nardacci, R., Ippolito, G., Tripodi, M., Garcia–Monzon, C., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.11.033 · Cited by 69
Metabolic dysfunction and cancer in HCV: Shared pathways and mutual interactions
Leslie, J., Geh, D., Elsharkawy, A. M., Mann, D. A., & Vacca, M. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.01.029 · Cited by 61
Metadata
- Authors
- Huang, H., Sun, F., Owen, D. M., Li, W., Chen, Y., Gale, M., & Ye, J.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2007-04-03
- Volume
- 104
- Issue
- 14
- Pages
- 5848-5853
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2094733152
- Cited by
- 533
- References
- 40
- FWCI
- 28.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.